Skip to content

Fadi Alhafez, M.D.

NPI 1902839111ActiveIndividual· Internal Medicine· Spokane, WA

Internal Medicine (M.D.) in Spokane, Washington, licensed in OR, with an NPI issued in July 2006. Part D covered 90 prescriptions written in 2024, 98% of them generic. Revance Therapeutics, Inc. was the largest of 5 companies reporting payments in 2025, $812.15 in all, mostly food and beverage.

Overview

NPI1902839111
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJul 9, 2006
Last updated in NPPESApr 5, 2021
Certified by providerApr 5, 2021

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000XMD153218OR
Hospitalist208M00000XMD153218OR

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)90 · 108 30-day fills
Patients23
Total drug cost$3,755
Generic share98% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$812.15 · 23 payments from 5 companies
  • 2024$505.95 · 19 payments from 6 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$812.15 · 23 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in Spokane

All Internal Medicine providers in Washington →